I-OQORY™ (COVI-MSC) (I-Acute Respiratory Distress Syndrome – STI 8282)

I-Sorrento ingena kwiSigaba soku-I sovavanyo lwe-OQORY™ (COVI-MSC) kwizigulana eziphethwe yi-Acute Respiratory Distress Syndrome (ARDS) enxulumene ne-COVID-19, ethe yacinywa yi-FDA.

Eyona njongo iphambili yophononongo lweSigaba soku-1 kukuvavanya ukhuseleko lokufakwa kwi-intravenous of allogeneic adipose stem cells kwizigulana ezine-COVID-19 kunye nakuxinzelelo lokuphefumla. Injongo yesibini kukuvavanya uluhlu lweziphumo eziguquguqukayo zokhuseleko kunye nokusebenza ngempumelelo ukunika isikhokelo malunga nomngcipheko/umlinganiselo wenzuzo kwizigulana ezine-COVID-19 yoxinzelelo lokuphefumla.

Iiseli ze-Stem ziye zaboniswa ukuxhasa isisombululo seempawu kwiindawo ezininzi zezifo kwaye zinamandla okunciphisa imiphumo yexesha elide elihambelana nomonakalo wezicubu ze-pulmonary kwezi zi gulane. I-MSC imele uhlobo lonyango olunamandla aphezulu okunceda kumlo ochasene ne-COVID-19 njengonyango oluzimeleyo okanye kwintsebenziswano nabanye abagqatswa bemveliso kumbhobho weSorrento, kubandakanya iimolekyuli ezincinci (i-abivertinib okanye i-salicyn-30) kunye nezilwa-buhlungu (STI-) 1499 okanye STI 2020).